US Healthcare Journal
SEE OTHER BRANDS

Get your fresh news on healthcare and wellness in the United States

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on June 10, 2025

Tiny Health and Evexia Diagnostics Close the Gut Testing Access Gap

Tiny Health and Evexia Diagnostics Close the Gut Testing Access Gap

AUSTIN, Texas, June 10, 2025 (GLOBE NEWSWIRE) -- Over 40% of children in the U.S. now live with at least one chronic condition[1], many of which begin in the first few years and carry into adulthood. Yet access to advanced preventative microbiome testing …

Announcing the 2025 Philadelphia Titan 100 Recipients

Announcing the 2025 Philadelphia Titan 100 Recipients

BERWYN, Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Titan CEO is pleased to announce that Bill Oldham, chairman and president, AscellaHealth, has been inducted as one of only 10 honorees into the 2025 Philadelphia Titan 100 Hall of Fame, while John Campolongo, …

International Myeloma Foundation (IMF) to Honor 2025 Kyle and Durie Achievement Awardees, Dr. Sagar Lonial and Dr. Sonja Zweegman 

International Myeloma Foundation (IMF) to Honor 2025 Kyle and Durie Achievement Awardees, Dr. Sagar Lonial and Dr. Sonja Zweegman 

MILAN, June 10, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the International Myeloma Working Group (IMWG) are proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding …

Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split

Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split

CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced a reverse stock split of its issued and outstanding …

Shades for Migraine Drives Awareness and Action to Break Migraine Stigma

Shades for Migraine Drives Awareness and Action to Break Migraine Stigma

Providence, RI, June 10, 2025 (GLOBE NEWSWIRE) -- The nonprofit Association of Migraine Disorders is changing the conversation around migraine disease through its global Shades for Migraine awareness campaign. Combining visibility with action, Shades for …

Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution

Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new collaboration with Amazon’s Health Benefits Connector to expand access to comprehensive women’s …

Roji Health Intelligence Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity

Roji Health Intelligence Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity

CHICAGO, June 10, 2025 (GLOBE NEWSWIRE) -- Roji Health Intelligence LLC, a leading provider of Value-Based Care technology and services to health care providers, today announced that its Roji Clinical Data Registry, ”Roji Registry”, has earned certified …

Ensemble and Cohere Launch End-to-End Agentic AI Platform for Integrated Revenue Cycle Orchestration

Ensemble and Cohere Launch End-to-End Agentic AI Platform for Integrated Revenue Cycle Orchestration

CINCINNATI, Ohio, June 10, 2025 (GLOBE NEWSWIRE) -- Ensemble, the industry leader in end-to-end revenue cycle management (RCM), today announced the launch of a transformational agentic AI platform for RCM in partnership with Cohere, the leading security- …

Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension

Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension

NORCROSS, Ga., June 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will host a virtual …

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

MALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …

MetaVia to Present at the Life Sciences Virtual Investor Forum June 12th

MetaVia to Present at the Life Sciences Virtual Investor Forum June 12th

CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Officer will …

Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025

Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025

Dr. Gül Dölen, MD, PhD, to share groundbreaking research on how psychedelic compounds can reopen “critical periods” of brain plasticity. Rotem Petranker, PhD, to discuss the latest findings from controlled clinical trials investigating the effects of …

GSAC Engineering Secures Multi-Year Recurring Revenue Contract

GSAC Engineering Secures Multi-Year Recurring Revenue Contract

MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTC: GSAC), a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security industries, …

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One Dr. Vasconcelles to drive pipeline creation and execution BRISBANE, Calif., June 10 …

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present …

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

ISELIN, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medicines …

Noom Expands Board of Directors with Appointment of Global Health Leader Dr. David Luu

Noom Expands Board of Directors with Appointment of Global Health Leader Dr. David Luu

Dr. Luu’s experience as a visionary heart surgeon and longevity health-tech entrepreneur positions him to support Noom’s long-term strategic mission NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to …

Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt

Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt

Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments Company is exploring new technology to normalize VEGF expression, …

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions

CARMEL, Ind., June 10, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025. AHIP is a national business organization whose …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service